Archives

Perfusfind S.L.

Abstract Early right heart failure (RHF) occurs in up to 40% of patients following left ventricular assist device (LVAD) implantation and is associated with increased morbidity and mortality. The most recent..

Perfusfind S.L.

Abstract Initial reports described a hypercoagulable state and an increased risk of thrombosis in patients who tested positive for SARS-CoV-2. Infected patients with severe acute respiratory distress syndrome in the setting of..

Perfusfind S.L.

Abstract Nearly 90% of COVID-19 patients who qualified for, but did not receive, ECMO (extracorporeal membrane oxygenation) due to a shortage of resources during the height of the pandemic died..

Perfusfind S.L.

Abstract Purpose Extracorporeal membrane oxygenation (ECMO) has become an established therapy for severe respiratory failure in coronavirus disease 2019 (COVID-19). The added benefit of receiving ECMO in COVID-19 remains uncertain...

Perfusfind S.L.

Abstract Background: Little data is published describing the use of medications prescribed for pulmonary arterial hypertension (PAH) in patients receiving extracorporeal membrane oxygenation (ECMO). Even though many patients with PAH..

Perfusfind S.L.

Abstract COVID-19 has ravished the world, with secondary consequences that are not yet possible to estimate. WHO and the European Extracorporeal Life Support Organization (ELSO) recommended extracorporeal membrane oxygenation (ECMO)..

Perfusfind S.L.

Abstract Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) creates a retrograde flow along the aorta competing with the left ventricle (LV) in the so-called ‘mixing zone’ (MZ). Detecting it..

Perfusfind S.L.

Abstract El uso de la técnica de oxigenación mediante membrana extracorpórea (ECMO), en su configuración venovenosa (V-V), en pacientes con síndrome de distrés respiratorio agudo (SDRA) ha aumentado en los..

Perfusfind S.L.

Abstract The role of extracorporeal membrane oxygenation (ECMO) in the management of severe acute respiratory failure, including the acute respiratory distress syndrome, has become better defined in recent years in..

Perfusfind S.L.

Abstract Objectives This study aimed at investigating the effects of an extracorporeal membrane oxygenation (ECMO) service, on Burnout syndrome (BOS) development in the intensive care unit (ICU). Design We conducted..

Perfusfind S.L.

Abstract Objectives:  Data about inhospital outcomes in bleeding complications during extracorporeal life support (ECLS) have been poorly investigated. Design:  Retrospective observational study. Setting:  Patients reported in Extracorporeal Life Support Organization..

Perfusfind S.L.

Abstract Purpose To determine if a cannulation method for venovenous extracorporeal membrane oxygenation (V-V ECMO) is related to patient outcome. Methods A retrospective, multi-center study of adult patients (≥18 years..

Perfusfind S.L.

Abstract Introduction  (ECMO) can be life-saving, but suffers from  in the circuit with associated risks of  occlusion,  and . The formation of thrombin is the key step to thrombus formation and two factors are..

Perfusfind S.L.

Abstract Cardiac arrest is an important public health concern, affecting an estimated 356,500 people in the out-of-hospital setting and 209,000 people in the in-hospital setting each year. The causes of..

Perfusfind S.L.

Abstract Cardiac arrest (CA) is a frequent cause of death and a major public health issue. To date, conventional cardiopulmonary resuscitation (CPR) is the only efficient method of resuscitation available..

Perfusfind S.L.

Abstract Extracorporeal lung support includes the risk of hemolysis due to suction pressures. Manufacturers measure the negative suction pressure across drainage cannulas for their products in vitro using water. Clinical experience suggests..

Perfusfind S.L.

Abstract Although acute right ventricular (RV) failure is uncommon, it is associated with a poor prognosis and high mortality. A range of devices now exist to provide temporary mechanical circulatory..

Perfusfind S.L.

Abstract Purpose: The question of whether cancer patients with severe respiratory failure beneft from veno-venous extracorporeal membrane oxygenation (vv-ECMO) remains unanswered. We, therefore, analyzed clinical characteristics and outcomes of a..

Perfusfind S.L.

Abstract Objectives The  (COVID-19) pandemic has been associated with cases of refractory  (ARDS) sometimes requiring support with  (ECMO).  can be used for  in patients on ECMO support, but its efficacy and safety in patients with..

Perfusfind S.L.

Abstract Objective Bleeding and thrombosis are common complications during Extracorporeal Membrane Oxygenation (ECMO) support for COVID-19 patients. We sought to examine the relationship between inflammatory status, coagulation effects, and observed..

Perfusfind S.L.

Abstract We report a case of Kounis syndrome that led to shock after protamine administration during percutaneous coronary intervention (PCI). A man in his 50s was admitted to the nearest..

Perfusfind S.L.

Abstract Background Patients with  (COVID-19)-related  (ARDS) increasingly receive  (ECMO) support. While ECMO has been shown to increase risk of stroke, few studies have examined this association in COVID-19 patients. Objective We conducted a..

Perfusfind S.L.

Abstract The dramatic increase in the use of extracorporeal membrane oxygenation (ECMO) over the last decade with the concomitant need for ECMO competent perfusionists has raised questions of how well..

Perfusfind S.L.

Abstract There are quarter of a million articles in PubMed since the wake of the COVID-19 pandemic with about fifteen hundred articles on extracorporeal membrane oxygenation (ECMO) alone. Those that are entrenched..

Perfusfind S.L.

Abstract Background Venoarterial extracorporeal membrane oxygenation (ECMO) provides mechanical support for critically ill patients with cardiogenic shock. Typically, the size of the arterial return cannula is chosen to maximize flow...

Perfusfind S.L.

Abstract Peripheral venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute cardiac failure reestablishes normal oxygen delivery and perfusion. However, VA ECMO can be limited by insufficient ventricular unloading, resulting in..

Perfusfind S.L.

Abstract We read with great interest the paper of Giani and colleagues titled "Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a pooled individual patient data..

Perfusfind S.L.

Abstract Respiratory failure caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is associated with mortality. Patients unresponsive to conventional therapy may benefit from temporary venovenous extracorporeal membrane oxygenation (VV-ECMO). We..

Perfusfind S.L.

Abstract The outcome of COVID-19 patients treated on intensive care units (ICU) is unsatisfying (1). Veno-venous extracorporeal membrane oxygenation (vv-ECMO) can serve as a rescue strategy when patients deteriorate during..

Perfusfind S.L.

Abstract Purpose: This study aimed at analyzing the prevalence, mortality association, and risk factors for bleeding and thrombosis events (BTEs) among adults supported with venovenous extracorporeal membrane oxygenation (VV-ECMO). Methods:..